Jaye Thompson

Jaye Thompson, Ph.D., is the Vice President of Clinical and Regulatory Affairs at Greenwich LifeSciences (GLSI).14 She is a highly experienced professional in the pharmaceutical and medical device industries with over 30 years of expertise in product development.1

Professional Background

Dr. Thompson is a biostatistician with extensive clinical trial and regulatory expertise.2 She has played significant roles in various companies and organizations:

• Co-founder and clinical advisor of Proxima Clinical Research, Inc.
• Founder and former President of Synergos, Inc. (both clinical research service providers)
• Former Senior Vice President of Clinical and Regulatory Affairs at Repros Therapeutics, Inc.
• Former Senior Vice President of Clinical Development and Regulatory Affairs at Opexa Therapeutics, Inc.

Education and Expertise

Dr. Thompson's educational background includes:

• BS in Applied Mathematics from Texas A&M University
• MS and Ph.D. in Biostatistics from the University of Texas Health Science Center in Houston1

Her areas of expertise encompass:

• Strategic and regulatory planning
• Clinical product development
• Statistical analysis and data management
• Clinical trial management

Achievements and Contributions

Throughout her career, Dr. Thompson has:

• Been actively involved in over 200 clinical trials for drugs, biologics, and devices
• Represented sponsor companies at FDA meetings and advisory committee meetings
• Directed and managed various aspects of clinical trials for a wide range of indications
• Been appointed to the Governor's Texas Emerging Technology Fund Advisory Committee1

Dr. Thompson's extensive experience and expertise make her a valuable asset to Greenwich LifeSciences, where she manages crucial aspects of clinical trials and regulatory affairs.3